                         SEQUENCE LISTING

<110>  Hytest, Ltd.
 
<120>  METHODS AND BIOMARKERS FOR PREDICTING EFFICACY AND EVALUATION OF 
       TREATMENT WITH DRUGS MODULATING NEPRILYSIN ACTIVITY.

<130>  77323PC9

<150>  US62/786,825
<151>  2018-12-31

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  28
<212>  PRT
<213>  homo sapiens

<400>  1

Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Met Asp Arg Ile Gly 
1               5                   10                  15      


Ala Gln Ser Gly Leu Gly Cys Asn Ser Phe Arg Tyr 
            20                  25              


<210>  2
<211>  32
<212>  PRT
<213>  homo sapiens

<400>  2

Ser Pro Lys Met Val Gln Gly Ser Gly Cys Phe Gly Arg Lys Met Asp 
1               5                   10                  15      


Arg Ile Ser Ser Ser Ser Gly Leu Gly Cys Lys Val Leu Arg Arg His 
            20                  25                  30          


